Austin A.B. Ownbey

Representative Experience

• Prepared HSR filing and provided antitrust guidance to New-Indy Containerboard, a joint-venture formed by the Kraft Group and Schwarz Partners, LP, in its acquisition of Shoreline Container
• Prepared HSR filing and provided antitrust guidance to Cultivate Holdings in executing a definitive agreement to sell 100% of its business to Cresco Labs (CSE:CL) (OTCQX:CRLBF)
• Provided antitrust guidance to global cannabis operator Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) in signing a definitive agreement to acquire Green Leaf Medical, LLC, a privately held, fully integrated cannabis multi-state operator based in the mid-Atlantic region
• Prepared HSR filing and provided antitrust guidance to New England Treatment Access, LLC (NETA), a leading Massachusetts-based cannabis company, in its sale to Surterra Wellness
• Represented major company as a third-party witness in a merger challenge in the internet listing services provider industry brought by the FTC
• Obtained regulatory approval for $1.8 billion merger of equals, creating the leading in-home health care provider in the U.S. with more than 780 locations in 36 states*
• Represented large regional healthcare system, in obtaining antitrust approval for membership substitution transaction with not-for-profit, community health system comprised of 11 hospitals*
• Represented one of the largest recyclers of poultry products in the world in its $800 million sale of substantially all its assets to one of the largest U.S. food companies, obtaining unconditional clearance for the transaction that combined the two largest poultry rendering companies in the U.S.*
• Represented a leading global payments solutions provider, in obtaining clearance for its acquisition a payment technology company, in a transaction valued at $1.05 billion*
• Represented a leading health-services company in a multistate antitrust and consumer protection investigation relating to pharmaceutical pricing*
• Represented a multinational medical device company in connection with a Federal Trade Commission investigation into the acquisition of a competitor, successfully negotiating a consent decree that allowed the client to complete the acquisition*
• Advised major pharmaceutical companies on compliance with the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and worked with clients to prepare and file required documentation with the Federal Trade Commission*
• Represented one of the largest oilfield services companies in the world on its attempted acquisition of a major competitor*
• Represented company that specializes in the treatment, storage, & disposal of radioactive, hazardous, and mixed wastes during its attempted sale to one of the world's largest processors of low level nuclear waste*

* - Handled by lawyer prior to joining the firm

Professional Experience

• Federal Trade Commission, staff attorney
• California Attorney General, Antitrust Law Section, Dean’s Fellow